A Multi-Center, Randomized, Parallel, Double-Blind, Phase III Clinical Trial to Compare the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy With DWC20155 or DWC20156 Monotherapy in Patients With Gastritis
Latest Information Update: 17 Jan 2020
At a glance
- Drugs DWJ 1366 (Primary) ; DWC 20155; DWC 20156
- Indications Gastritis
- Focus Registrational; Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 25 Jun 2019 Status changed from not yet recruiting to discontinued.
- 15 Jun 2017 New trial record